Questions and Answers for Pharmacies: Policy for Methadone Maintenance Treatment (MMT) Reimbursement under the Ontario Drug Benefit Program

Effective August 31, 2022, two generic formulations of methadone hydrochloride 10mg/mL oral concentrate from two manufacturers (Jamp Methadone DIN 02495783 and Odan-Methadone DIN 02495880) will be listed as interchangeable, with Methadose (unflavoured) DIN 02394618.  As of September 29, 2022), the lowest cost interchangeable Drug Benefit Price is paid for a methadone product in an interchangeable category. It is important that pharmacists have discussions with their individual patients and prescribers about appropriate supports being in place to ensure patient safety for transitioning to an interchangeable generic product.

Français : https://www.health.gov.on.ca/fr/pro/programs/drugs/opdp_eo/notices/fq_e…